ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BOW Bowhead Specialty Holdings Inc

36.84
0.68 (1.88%)
29 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Bowhead Specialty Holdings Inc NYSE:BOW NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.68 1.88% 36.84 37.12 36.39 36.60 85,024 22:00:00

Bowhead Specialty Holdings Inc. Reports Second Quarter 2024 Results

06/08/2024 12:00pm

Business Wire


Bowhead Specialty (NYSE:BOW)
Historical Stock Chart


From May 2024 to Nov 2024

Click Here for more Bowhead Specialty Charts.

Bowhead Specialty Holdings Inc. (NYSE: BOW), a growing specialty lines insurance group focused on providing casualty, professional liability and healthcare liability insurance products, today announced financial results for the second quarter ended June 30, 2024*.

Second Quarter 2024 Highlights

  • Gross written premiums increased 50.4% to $175.5 million.
  • Net income of $5.5 million, or $0.20 per diluted share.
  • Adjusted net income(1) of $7.9 million, or $0.28 per diluted share(1).
  • Return on equity of 8.2% and adjusted return on equity(1) of 11.7%.
  • Upsized initial public offering completed in May 2024, raising $131.0 million in net proceeds through the issuance of 8,658,823 shares of common stock at $17.00 per share.
___________________

(1) Non-GAAP financial measure. See “—Reconciliation of Non-GAAP Financial Measures” for a reconciliation of the non-GAAP financial measures to their most directly comparable U.S. GAAP measures.

Bowhead Chief Executive Officer Stephen Sills commented, “We are very pleased with what we have to report for the results of our first quarter as a publicly traded company. We opened our doors for business as a specialty insurance underwriter in November of 2020. Over the next three plus years, we assembled a great team of over 200 employees to get us to where we are today. In May of this year, we launched an IPO to raise $100 million, which was ultimately upsized to $131 million in net proceeds. We’ve achieved our position of prominence in the specialty insurance space by building a highly experienced team focused on underwriting profitability through market cycles. We continue to believe we can attract high quality talent and generate profitable business.”

Mr. Sills continued, “Those that followed us through the IPO process will recall that almost 80% of our business is in the E&S market. The favorable market dynamics we saw then still exist today. In fact, because of the ongoing deteriorating loss experience in certain sectors and the market’s resulting need to reprice risks, we see lasting tailwinds for Bowhead, which is free of these legacy risks.”

Underwriting Results

The 50.4% increase in gross written premiums to $175.5 million in the second quarter of 2024 was driven by new business, renewals and continued growth in our platform across all divisions:

  • Our Casualty division led the growth with a 78.8% increase to $114.2 million;
  • Healthcare increased 46.4% over the same period to $16.9 million; and
  • Professional Liability increased 7.5% to $44.4 million.
  • Late in the second quarter of 2024, we launched a new division called Baleen, which focuses on small, hard-to-place risks written 100% on a non-admitted basis. Baleen is a streamlined, low touch “flow” underwriting operation that supplements the “craft” solutions we offer today. In line with our deliberate, measured and limited roll out, Baleen gross written premiums for the second quarter of 2024 was minimal. We will report Baleen’s first full quarter gross written premiums during our third quarter earnings call.

Our loss ratio of 65.5% in the second quarter of 2024 utilizes the same industry loss ratios used since the fourth quarter of 2023 and remained unchanged compared to the first quarter of 2024. There were no changes to loss picks or prior year reserves during the quarter. As of June 30, 2024, incurred but not reported liabilities comprised 92.0% of our net loss reserves.

Our expense ratio of 33.8% included $1.3 million of remaining stock-based compensation costs associated with management’s profit interest through operating expenses. Excluding this one-time increase in operating expenses, our expense ratio for the second quarter of 2024 would be 32.3%, a decrease compared to our first quarter of 2024 expense ratio of 32.6%.

Investment Results

Net investment income was $8.8 million, driven by the increase in our investment portfolio and higher yields on invested assets. Our investment portfolio included $131.0 million of net proceeds from our IPO, which were not invested for the full quarter. Excluding the net proceeds from our IPO, our investment portfolio had a book yield of 4.6% and our new money rate was 5.5% at the end of the quarter.

Excluding the net proceeds from our IPO, the weighted average effective duration of our investment portfolio, which included cash equivalents, increased from 1.9 years at March 31, 2024 to 2.1 years at June 30, 2024, and had an average rating of “AA” at June 30, 2024.

___________________

* Comparisons in this release are made to June 30, 2023 financial results unless otherwise noted.

Summary of Operating Results

The following table summarizes the Company’s results of operations for the three months ended June 30, 2024 and 2023:

 

Three Months Ended June 30,

 

 

2024

 

 

2023

 

$ Change

 

% Change

($ in thousands, except percentages and per share data)

Gross written premiums

$

175,539

 

$

116,742

 

$

58,797

 

50.4 %

Ceded written premiums

 

(63,486)

 

 

(40,310)

 

 

(23,176)

 

57.5 %

Net written premiums

$

112,053

 

$

76,432

 

$

35,621

 

46.6 %

 

 

 

 

 

 

 

 

Revenues

 

 

 

 

 

 

 

Net earned premiums

$

90,087

 

$

61,374

 

$

28,713

 

46.8 %

Net investment income

 

8,777

 

 

4,048

 

 

4,729

 

116.8 %

Net realized investment gains

 

2

 

 

 

 

2

 

NM

Other insurance-related income

 

32

 

 

31

 

 

1

 

4.8 %

Total revenues

 

98,898

 

 

65,453

 

 

33,445

 

51.1 %

 

 

 

 

 

 

 

 

Expenses

 

 

 

 

 

 

 

Net losses and loss adjustment expenses

 

59,018

 

 

37,409

 

 

21,609

 

57.8 %

Net acquisition costs

 

7,582

 

 

4,960

 

 

2,622

 

52.9 %

Operating expenses

 

22,855

 

 

14,616

 

 

8,239

 

56.4 %

Non-operating expenses

 

1,481

 

 

 

 

1,481

 

NM

Warrant expense

 

332

 

 

 

 

332

 

NM

Credit facility interest expenses and fees

 

224

 

 

 

 

224

 

NM

Foreign exchange (gains) losses

 

(4)

 

 

8

 

 

(12)

 

(148.5) %

Total expenses

 

91,488

 

 

56,993

 

 

34,495

 

60.5 %

 

 

 

 

 

 

 

 

Income before income taxes

 

7,410

 

 

8,460

 

 

(1,050)

 

(12.4) %

Income tax expense

 

(1,877)

 

 

(1,905)

 

 

28

 

(1.5) %

Net income

$

5,533

 

$

6,555

 

$

(1,022)

 

(15.6) %

 

 

 

 

 

 

 

 

Key Operating and Financial Metrics:

 

 

 

 

 

 

 

Adjusted net income(1)

$

7,880

 

$

6,561

 

$

1,319

 

20.1 %

Loss ratio

 

65.5 %

 

 

61.0 %

 

 

 

 

Expense ratio

 

33.8 %

 

 

31.9 %

 

 

 

 

Combined ratio

 

99.3 %

 

 

92.8 %

 

 

 

 

Return on equity(2)

 

8.2 %

 

 

22.2 %

 

 

 

 

Adjusted return on equity(1)(2)

 

11.7 %

 

 

22.2 %

 

 

 

 

Diluted earnings per share

$

0.20

 

$

0.27

 

 

 

 

Diluted adjusted earnings per share(1)

$

0.28

 

$

0.27

 

 

 

 

__________________ NM - Percentage change is not meaningful. (1) Non-GAAP financial measure. See “—Reconciliation of Non-GAAP Financial Measures” for a reconciliation of the non-GAAP financial measures to their most directly comparable U.S. GAAP measures. (2) For the three months ended June 30, 2024 and 2023, net income and adjusted net income are annualized to arrive at return on equity and adjusted return on equity.

Condensed Consolidated Balance Sheets

 

June 30, 2024

 

December 31, 2023

 

($ in thousands, except share data)

Assets

 

 

 

Investments

 

 

 

Fixed maturity securities, available for sale, at fair value (amortized cost of $721,782 and $569,013, respectively)

$

706,199

 

$

554,624

Short-term investments, at amortized cost, which approximates fair value

 

12,712

 

 

8,824

Total investments

 

718,911

 

 

563,448

 

 

 

 

Cash and cash equivalents

 

180,324

 

 

118,070

Restricted cash and cash equivalents

 

18,494

 

 

1,698

Accrued investment income

 

6,728

 

 

4,660

Premium balances receivable

 

69,495

 

 

38,817

Reinsurance recoverable

 

192,025

 

 

139,389

Prepaid reinsurance premiums

 

133,992

 

 

116,732

Deferred policy acquisition costs

 

24,564

 

 

19,407

Property and equipment, net

 

7,481

 

 

7,601

Income taxes receivable

 

1,320

 

 

1,107

Deferred tax assets, net

 

17,071

 

 

14,229

Other assets

 

24,768

 

 

2,701

Total assets

$

1,395,173

 

$

1,027,859

 

 

 

 

Liabilities

 

 

 

Reserve for losses and loss adjustment expenses

$

587,905

 

$

431,186

Unearned premiums

 

391,802

 

 

344,704

Reinsurance balances payable

 

45,767

 

 

40,440

Income taxes payable

 

29

 

 

42

Accrued expenses

 

11,287

 

 

14,900

Other liabilities

 

18,472

 

 

4,510

Total liabilities

 

1,055,262

 

 

835,782

 

 

 

 

Commitments and contingencies (Note 13)

 

 

 

 

 

 

Mezzanine equity

 

 

 

Performance stock units

 

46

 

 

 

 

 

 

Stockholders' equity

 

 

 

Common stock

 

327

 

 

240

($0.01 par value; 400,000,000 shares authorized, 32,658,823 and 24,000,000 shares issued and outstanding at June 30,2024 and December 31,2023, respectively)

 

 

 

Additional paid-in capital

 

314,636

 

 

178,543

Accumulated other comprehensive loss

 

(12,309)

 

 

(11,372)

Retained earnings

 

37,211

 

 

24,666

Total stockholders' equity

 

339,865

 

 

192,077

Total mezzanine equity and stockholders' equity

 

339,911

 

 

192,077

 

 

 

 

Total liabilities, mezzanine equity and stockholders' equity

$

1,395,173

 

$

1,027,859

Gross Written Premiums

The following table presents gross written premiums by underwriting division for the three months ended June 30, 2024 and 2023:

 

Three Months ended June 30,

 

 

2024

 

% of Total

 

 

2023

 

% of Total

 

$ Change

 

% Change

 

($ in thousands, except percentages)

Casualty

$

114,233

 

65.1 %

 

$

63,890

 

54.7 %

 

$

50,343

 

78.8 %

Professional Liability

 

44,397

 

25.3 %

 

 

41,302

 

35.4 %

 

 

3,095

 

7.5 %

Healthcare

 

16,909

 

9.6 %

 

 

11,550

 

9.9 %

 

 

5,359

 

46.4 %

Gross written premiums

$

175,539

 

100.0 %

 

$

116,742

 

100.0 %

 

$

58,797

 

50.4 %

Loss Ratio

The following table summarizes current and prior accident loss ratios for the three months ended June 30, 2024 and 2023:

 

Three Months Ended June 30,

 

2024

 

2023

 

Net Losses and Loss Adjustment Expenses

 

% of Net Earned Premiums

 

Net Losses and Loss Adjustment Expenses

 

% of Net Earned Premiums

 

($ in thousands, except percentages)

Current accident year

$

59,018

 

65.5 %

 

$

37,148

 

60.5 %

Prior accident year reserve development

 

 

— %

 

 

261

 

0.4 %

Total

$

59,018

 

65.5 %

 

$

37,409

 

61.0 %

Expense Ratio

The following table summarizes the components of our expense ratio for the three months ended June 30, 2024 and 2023:

 

Three Months Ended June 30,

 

2024

 

2023

 

Expenses

 

% of Net Earned Premium

 

Expenses

 

% of Net Earned Premium

 

($ in thousands, except percentages)

Net acquisition costs

$

7,582

 

8.4 %

 

$

4,960

 

8.1 %

Operating expenses

 

22,855

 

25.4 %

 

 

14,616

 

23.8 %

Total expense ratio

$

30,437

 

33.8 %

 

$

19,576

 

31.9 %

Net Investment Income

The following table summarizes the sources of net investment income for the three months ended June 30, 2024 and 2023:

 

Three Months Ended June 30,

 

 

2024

 

 

2023

 

($ in thousands)

U.S. government and government agency

$

3,836

 

$

656

State and municipal

 

388

 

 

388

Commercial mortgage-backed securities

 

468

 

 

363

Residential mortgage-backed securities

 

1,920

 

 

246

Asset-backed securities

 

(33)

 

 

894

Corporate

 

1,071

 

 

893

Short-term investments

 

103

 

 

208

Cash and cash equivalents

 

1,204

 

 

511

Gross investment income

 

8,957

 

 

4,159

Investment expenses

 

(180)

 

 

(111)

Net investment income

$

8,777

 

$

4,048

Reconciliation of Non-GAAP Financial Measures

This earnings release contains certain financial measures that are not presented in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). We use these non-GAAP financial measures when planning, monitoring and evaluating our performance. Management believes that each of the non-GAAP financial measures described below provides useful insight into our underlying business performance.

  • Adjusted net income is defined as net income excluding the impact of net realized investment gains, non-operating expenses, foreign exchange (gains) losses, and certain strategic initiatives. Adjusted net income excludes the impact of certain items that may not be indicative of underlying business trends, operating results, or future outlook, net of tax impact. We calculate the tax impact only on adjustments which would be included in calculating our income tax expense using the estimated tax rate at which we received a deduction for these adjustments.
  • Adjusted return on equity is defined as adjusted net income as a percentage of average beginning and ending mezzanine equity and stockholders’ equity.
  • Diluted adjusted earnings per share is defined as adjusted net income divided by the weighted average common shares outstanding for the period, reflecting the dilution that may occur if equity base awards are converted into common stock equivalents as calculated using the treasury stock method.

You should not rely on these non-GAAP financial measures as a substitute for any U.S. GAAP financial measure. While we believe that these non-GAAP financial measures are useful in evaluating our business, this information should be considered supplemental in nature and not as a replacement for or superior to the comparable U.S. GAAP measures. In addition, other companies, including companies in our industry, may calculate such measures differently, which reduces their usefulness as comparative measures.

Adjusted net income

Adjusted net income for the three months ended June 30, 2024 and 2023 reconciles to net income as follows:

 

Three Months Ended June 30,

 

2024

 

2023

 

Before income taxes

 

After income taxes

 

Before income taxes

 

After income taxes

 

($ in thousands)

Income as reported

$

7,410

 

$

5,533

 

$

8,460

 

$

6,555

Adjustments:

 

 

 

 

 

 

 

Net realized investment gains

 

(2)

 

 

(2)

 

 

 

 

Non-operating expenses

 

1,481

 

 

1,481

 

 

 

 

Foreign exchange (gains) losses

 

(4)

 

 

(4)

 

 

8

 

 

8

Strategic initiatives(1)

 

1,496

 

 

1,496

 

 

 

 

Tax impact

 

 

 

(624)

 

 

 

 

(2)

Adjusted net income

$

10,381

 

$

7,880

 

$

8,468

 

$

6,561

___________________

(1) Strategic initiatives for the three months ended June 30, 2024 represents costs incurred to set up our Baleen Specialty division, which is recorded in operating expenses within the Condensed Consolidated Statements of Income and Comprehensive Income. The costs incurred primarily represent expenses to implement the new platform and processes supporting the Baleen Specialty division. See “Business— Our Strategy”

Adjusted return on equity

Adjusted return on equity for the three months ended June 30, 2024 and 2023 reconciles to return on equity as follows:

 

Three Months Ended June 30,

 

2024

 

2023

 

($ in thousands, except percentages)

Numerator: Adjusted net income(1)

31,519

 

26,245

Denominator: Average mezzanine equity and stockholders' equity

270,551

 

118,144

Adjusted return on equity

11.7 %

 

22.2 %

___________________

(1) For the three months ended June 30, 2024, and 2023, net income and adjusted net income are annualized to arrive at return on equity and adjusted return on equity.

Diluted adjusted earnings per share

Diluted adjusted earnings per share for the three months ended June 30, 2024 and 2023 reconciles to diluted earnings per share as follows:

 

Three Months Ended June 30,

 

 

2024

 

 

2023

 

($ in thousands, except share and per share data)

Numerator: Adjusted net income

$

7,880

 

$

6,561

Denominator: Diluted weighted average shares outstanding

 

27,771,108

 

 

24,000,000

Diluted adjusted earnings per share

$

0.28

 

$

0.27

About Bowhead Specialty Holdings Inc.

Bowhead Specialty is a growing specialty insurance business providing casualty and professional liability insurance products. We were founded and are led by industry veteran Stephen Sills. The team is composed of highly experienced and respected industry veterans with decades of individual, successful underwriting and management experience. We focus on providing “craft” solutions in our specialty lines and classes of business that we believe require deep underwriting and claims expertise in order to produce attractive financial results.

We pride ourselves on the quality and experience of our people, who are committed to exceeding our partners’ expectations through excellent service and expertise. Our collaborative culture spans all functions of our business and allows us to provide a consistent, positive experience for all of our partners.

Conference Call

The Company will host a conference call to discuss its results on the same day, Tuesday, August 6, 2024, beginning at 8:30 a.m. Eastern Time. Interested parties may access the conference call through a live webcast, which can be accessed via this link or by visiting the Company’s Investor Relations website, or by dialing (866) 682-6100 (toll-free) or (862) 298-0702 (international). Please join the live webcast or dial in at least 10 minutes before the start of the call.

A replay of the event webcast will be available on the company’s Investor Relations website for one year following the call.

Forward-Looking Statements

This press release contains forward-looking statements. All statements other than statements of historical facts contained in press release are forward-looking statements. In some cases, forward-looking statements can be identified by terms such as "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "projects," "seeks," "future," "outlook," "prospects" "will," "would," "should," "could," "may," "can have" or similar words. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. These risks include those described under the caption "Risk Factors" in the Company's registration statement on Form S-1, Quarterly Report on Form 10-Q and other filings made with the Securities and Exchange Commission. Forward-looking statements speak only as of the date of this press release and the Company does not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events or otherwise.

Investor Relations: Shirley Yap, Head of Investor Relations investorrelations@bowheadspecialty.com

1 Year Bowhead Specialty Chart

1 Year Bowhead Specialty Chart

1 Month Bowhead Specialty Chart

1 Month Bowhead Specialty Chart

Your Recent History

Delayed Upgrade Clock